{"disease":{"id":"hepatocellular-carcinoma-with-portal-vein-tumor-thrombus","name":"hepatocellular carcinoma with portal vein tumor thrombus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04619342","title":"Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":98,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT04850157","title":"Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}